[an error occurred while processing this directive]
调查研究

中国大陆地区腹膜透析医保报销及诊疗收费情况的调查分析

  • 陈晓君 ,
  • 刘虹 ,
  • 赵新菊 ,
  • 韦洮 ,
  • 左力
展开
  • 中国医院协会血液净化中心分会

收稿日期: 2023-03-28

  修回日期: 2023-04-01

  网络出版日期: 2023-05-12

Investigation and analyses on the peritoneal dialysis fees and the reimbursement from medical insurance in Chinese mainland

  • CHEN Xiao-Jun ,
  • LIU Hong ,
  • ZHAO Xin-Ju ,
  • WEI Tao ,
  • ZUO Li
Expand
  • Chinese Hospital Association Blood Purification Center Branch

Received date: 2023-03-28

  Revised date: 2023-04-01

  Online published: 2023-05-12

摘要

目的  了解各地区关于腹膜透析医保报销及诊疗收费项目的情况,推动腹膜透析诊疗标准化收费和完善患者医保报销细则,减少患者负担并促进腹膜透析的发展。 方法 采用自行设计的腹膜透析项目及医保情况问卷,对除香港特别行政区、澳门特别行政区、西藏自治区外中国大陆30个省、自治区或直辖市的137家开设腹膜透析中心的医院进行问卷调查。对数据进行描述性统计分析,采用Kruskal-Wallis秩和H检验分析各组间差异。 结果 30个省、自治区或直辖市的居民、城镇职工、退休职工腹膜透析报销比例的中位数分别为80.0%(70.0%,85.0%),85.0%(80.0%,90.0%),90.0%(80.0%,90.0%)。每月持续性不卧床腹膜透析(continuous ambulatory peritoneal dialysis,CAPD)透析总费用低于自动化腹膜透析(automated peritoneal dialysis,APD)(H =26.717, P<0.001)。随着每月CAPD或APD的总费用增高,每月可报销费用增高(H=58.367,P<0.001)。腹膜透析费用存在较大的地区差异性。部分地区未设立出口处肉芽切除、废液袋项目、腹膜透析内涤纶套剥除项目、腹膜透析导管相关性隧道炎治疗等项目(地区比例分别为63%,60%,50%,47%)。常用的如敷贴、废液袋、消毒用品等保障腹膜透析治疗安全的一次性无菌用品,在77%的省市均无报销。 结论 本研究分析了目前腹膜透析管理存在的问题,并建议:①持续加强基本医保管理体制和运行机制研究,完善对腹膜透析医疗服务的激励机制;②完善腹膜透析诊疗收费项目,提高医疗机构提供腹膜透析治疗的积极性; ③增加可医保报销的腹膜透析诊疗项目,保障患者腹膜透析的安全及质量。

本文引用格式

陈晓君 , 刘虹 , 赵新菊 , 韦洮 , 左力 . 中国大陆地区腹膜透析医保报销及诊疗收费情况的调查分析[J]. 中国血液净化, 2023 , 22(05) : 321 -326 . DOI: 10.3969/j.issn.1671-4091.2023.05.001

Abstract

Objective  To investigate the items and costs of peritoneal dialysis (PD) management and the reimbursement of the expenses by medical insurance in PD patients from different regions in China, in order to reduce the financial burden of the patients and to promote the use of PD through the standard items and prices of PD and the rational rules of reimbursement by medical insurance.  Methods  A self-designed questionnaire on PD items and medical insurance was used to investigate the PD patients in 137 hospitals that provide PD in 30 provinces and big cities in China. Descriptive statistical analysis was performed on the collected data, and Kruskal-Wallis rank sum H test was used to examine the differences among groups.  Results  The nationwide median rates of reimbursement by medical insurance were 80.0 (70.0, 85.0)%, 85.0 (80.0, 90.0)% and 90.0 (80.0, 90.0)% for residents, urban employees, and retired employees, respectively. The monthly expense of continuous ambulatory peritoneal dialysis (CAPD) was significantly lower than that of automated peritoneal dialysis (APD) (H=26.717, P<0.0001). The monthly reimbursable amount increased with the monthly total expense of CAPD or APD (H=58.367, P<0.001). The prices of PD varied significantly in different provinces and big cities. The prices of surgical removal of granulation tissue at the outlet, waste bag, removal of polyester cuff in PD tube, and treatment of PD catheter-related tunnel infections had not been set up in 63%, 60%, 50% and 47% provinces and big cities respectively. The commonly used disposable materials necessary for PD safety such as dressing, waste bag and disinfectants could not be reimbursed by medical insurance in 77% provinces and big cities.  Conclusions   This study analyzed the current administration situations of PD management. We therefore recommend that ①the organization and administration of the basic medical insurance system must be continuously reinforced, and the encouragement mechanisms underlying PD services must be improved; ② the prices of PD items should be properly adjusted to support the passions of the hospitals providing high quality of PD services, and ③ the reimbursable PD items are required to be increased to support the safety and quality of PD services.

参考文献

[1]李恒,陈江华.提高对终末期肾病肾脏替代一体化治疗的认识[J].现代实用医, 2016, 28(4):421-422 [2]中国医师协会肾脏内科医师分会,国家肾病专业医疗质量管理与控制中心.中国医师协会肾脏内科医师分会对肾脏内科医师在新型冠状病毒感染防控期间医疗工作的指导意见[S/OL][J]., 2020, :- [3]Marshall M R, Polkinghorne K R, Boudville N, et al.Home Versus Facility Dialysis and Mortality in Australia and New Zealand[J].Am J Kidney Dis, 2021, 78(6):826-836 [4]张叶, 杨莉.美国腹膜透析激励政策的经验及对我国的启示[J].中国卫生政策研究, 2022, 15(4):52-58 [5]Yu A W, Chau K F, Ho Y W, et al.Development of the " peritoneal dialysis first" model in Hong Kong[J].Perit Dial Int, 2007, 27 (Suppl 2):S53-55 [6]董捷,左力.合理选择自动化腹膜透析, 我们准备好了吗? [J].中华肾脏病杂志, 2010, 26(7):493-496 [7]曹字芳, 姒怡冰, 陶珺珺.居家自动化腹膜透析和持续性腹膜透析卫生经济学效益及应用效果比较 [J].护理研究, 2022, 36(6):5-5 [8]中国医师协会肾脏内科医师分会 中, 国家肾病专业医疗质量管理与控制中心.自动化腹膜透析中国专家共识[J].中华医学杂志, 2021, 101(6):388-399 [9]广东省医疗保障局.广东医保实施腹膜透析治疗费用包干政策减轻慢性肾脏病患者负担[EB/OL] [J]., (2021-06-07), :- [10]尹晓丽,王丽.腹膜透析患者并发感染性腹膜炎的高危因素分析及护理对策[J].中华全科医学, 2014, 12(3):481-483 [11]阳晓,严骏飞,余学清.艾考糊精腹透液的临床优势及获益人群[J].中华肾脏病杂志, 2021, 37(6):528-533 [12]Johnson D W, Vincent K, Blizzard S, et al.Cost savings from peritoneal dialysis therapy time extension using icodextrin [J].Adv Perit Dial, 2003, 19( ):81-85 [13]Boudville N, de Moraes T P.Guidelines on targets for solute and fluid removal in adults being treated with chronic peritoneal dialysis: 2019 Update of the literature and revision of recommendations[J].Perit Dial Int, 2020, 40(3):254-260 [14]Xu X, Ma T, Tian X, et al.Telemedicine and Clinical Outcomes in Peritoneal Dialysis: A Propensity-Matched Study[J].Am J Nephrol, 2022, 53(8-9):663-674
文章导航

/

[an error occurred while processing this directive]